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Abstract
Community-acquired lower respiratory tract infections (LRTI) and pneumonia (CAP) are common causes of morbidity
and mortality among those aged ≥65 years; a growing population in many countries. Detailed incidence estimates for
these infections among older adults in the United Kingdom (UK) are lacking. We used electronic general practice
records from the Clinical Practice Research Data link, linked to Hospital Episode Statistics inpatient data, to estimate
incidence of community-acquired LRTI and CAP among UK older adults between April 1997-March 2011, by age,
sex, region and deprivation quintile. Levels of antibiotic prescribing were also assessed. LRTI incidence increased
with fluctuations over time, was higher in men than women aged ≥70 and increased with age from 92.21 episodes/
1000 person-years (65-69 years) to 187.91/1000 (85-89 years). CAP incidence increased more markedly with age,
from 2.81 to 21.81 episodes/1000 person-years respectively, and was higher among men. For both infection groups,
increases over time were attenuated after age-standardisation, indicating that these rises were largely due to
population aging. Rates among those in the most deprived quintile were around 70% higher than the least deprived
and were generally higher in the North of England. GP antibiotic prescribing rates were high for LRTI but lower for
CAP (mostly due to immediate hospitalisation). This is the first study to provide long-term detailed incidence
estimates of community-acquired LRTI and CAP in UK older individuals, taking person-time at risk into account. The
summary incidence commonly presented for the ≥65 age group considerably underestimates LRTI/CAP rates,
particularly among older individuals within this group. Our methodology and findings are likely to be highly relevant to
health planners and researchers in other countries with aging populations.
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Introduction
Pneumonia and lower respiratory tract infections (LRTI) are
major causes of morbidity and mortality among those aged 65
years and over in the UK and other European countries [1–3].
The UK’s population is aging; recent estimates suggest that in
2035, 23% of the UK will be aged ≥65 years and 5% will be
≥85, compared to 17% and 2% respectively in 2010 [4]. The
‘oldest old’ (≥85 years) are at particularly high risk of infections
due to co-morbidities and waning immune function.
Community-acquired pneumonia (CAP) in older individuals is a
particular concern, as it can aggravate underlying co-
morbidities and have serious consequences [5]. Thus, the need
has been highlighted for new population-based studies of the
incidence of these infections among older adults in different
European locations [6].
There are few longitudinal studies on the burden of these
infections specifically amongst older adults in the UK. This is a
disparate group, including people working full-time and those
that require round-the-clock care. Available incidence
estimates vary, partly due to different age categorisations and
methods used [1,7,8], and community- and hospital-acquired
infections are rarely differentiated. Existing studies of regional
and socio-economic variations in incidence have not age-
stratified further after 65 years. Therefore there is a paucity of
information for this important and growing subsection of the
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population; it is essential that their LRTI burden is better
understood to enable planning and provision of health care.
The extent of antibiotic prescribing in general practice for both
LRTI and CAP among older adults also needs ongoing
assessment.
The aim of this study was to describe the incidence of
community-acquired LRTI and CAP among individuals aged
≥65 years between April 1997 and March 2011, using linked
electronic health records from primary and secondary care. We
describe how the incidence of these common infections varied
over time by age, sex, region and socioeconomic deprivation
and the extent of antibiotic prescribing in this group.
Methods
Data sources
The Clinical Practice Research Datalink (CPRD, formerly
known as GPRD) is a large UK-based electronic database of
primary care records which currently includes around 8% of the
UK population. The age, sex and regional distribution of
patients from contributing practices are representative of the
UK overall [9]. Anonymised patient-level information including
diagnoses (coded using Read codes), referrals to specialist
care, prescriptions, hospitalisations, demographic and lifestyle
details are included. Data from a practice are only used for
research after they have met a series of quality checks and
have been deemed ‘up to standard’ by CPRD.
Over 50% of English practices that contribute to CPRD
consent to linkage of their patients’ records to Hospital Episode
Statistics (HES) data. These contain information on all NHS
inpatient hospitalisations in England since 1997, with
diagnoses coded using ICD-10. Hospitalisations include one or
more ‘episodes’, each denoting a period of consultant care.
Study population and follow-up time
Patients aged ≥65 years between 1st April 1997 and 31st
March 2011 were eligible for inclusion. Follow-up began at the
latest of the study start date, patients’ 65th birthday, the date
CPRD deemed the practice ‘up to standard’ or 28 weeks after
patients’ registration (to exclude reports of historical illness that
are often recorded when a patient first joins a practice; the 28-
week period was chosen after analyses based on existing
methods) [10]. Follow-up ended at the earliest of the study end
date, death, transfer out of the CPRD or the practices’ last data
collection date. Patients who contributed at least one day of
follow-up were included in the study.
Codes used to define LRTI, hospitalisations and
antibiotics
Read and ICD-10 code lists for LRTI and within this list,
pneumonia were developed by three clinical epidemiologists,
including a consultant respiratory physician and a GP. An
estimated 50-70% of chronic obstructive pulmonary disease
(COPD) exacerbations are due to LRTI [11]; COPD
exacerbation codes that did not mention infection were also
identified for sensitivity analyses.
We examined evidence of hospitalisations to distinguish
between potentially hospital-acquired and community-acquired
infections. In the CPRD data, we identified hospitalisation
codes and relevant fields indicating hospitalisation in the
consultation, referral and clinical files (code lists available on
request).
Antibiotic therapy codes were identified and categorised by
their British National Formulary (BNF) subchapter, excluding
antituberculosis and antileprotic drugs [12–15].
LRTI/pneumonia illness-episode structure
Records containing LRTI or pneumonia codes were identified
in both CPRD and HES. In order to accommodate multiple
consultations for one illness, CPRD or primary HES LRTI/
pneumonia records within 28 days of each other were regarded
as part of the same illness-episode. The first record was
deemed the index date and the illness-episode finished 28
days after its last LRTI code. Within HES, only LRTI/
pneumonia codes recorded as the primary code of the first
episode of a hospitalisation (the condition the patient was
admitted for) were used when defining the index date, to avoid
including hospital-acquired infections.
As pneumonia formed a subset of LRTI, pneumonia illness-
episodes could start on the same date as an LRTI episode (if
the patient initially presented with pneumonia) or at some point
within an LRTI episode (if an LRTI had worsened).
Defining community-acquired illness
Incident cases of LRTI were regarded as hospital-acquired if
in the previous 14 days the patient had been discharged from
hospital (using HES records for any illness) or there was a
CPRD hospital code (using the unlinked data) [14,16–19].
Other variables
We used the ‘financial year’ definition of April–March to
ensure the winter peak of LRTI was not split across two years.
Age was grouped in five-year bands from 65 to 89 years, then
as ≥90 years. English regions were defined by Strategic Health
Authority (SHA). Index of Multiple Deprivation (IMD) quintile
(2007) was available at Office for National Statistics (ONS)
small area level (100 houses) for >50% of CPRD patients. The
IMD is calculated using seven domains: income, employment,
health deprivation and disability, education, skills and training,
barriers to housing and services, crime and living environment.
Analyses
At their simplest, incidence rates are calculated by dividing
the number of new episodes of illness by the person-time at
risk. Patients were considered not at risk of a community-
acquired LRTI during an LRTI illness-episode (whether
community or hospital-acquired), during a HES hospitalisation
or for the 14 days after any HES hospitalisation or CPRD
hospital code. This person-time was excluded from the
denominator when calculating incidence.
Incidence rates were calculated by year, sex, age, region of
England and IMD quintile. Poisson regression with random
effects was used to account for multiple illness-episodes per
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person. Incidence rates were directly age-standardised using
the ONS mid-year UK population estimates from 2004, and
95% confidence intervals (CI) were calculated.
We identified how many patients had been prescribed an
antibiotic on the illness index date, and the type of antibiotic
prescribed. Among those without a prescription on the index
date, we calculated the percentage that were hospitalised or
died as possible reasons for not having received a GP
prescription. For remaining patients, analyses were repeated
sequentially for the week after, and then two to four weeks after
the index date. Finally, records in the week before the index
date were examined to assess how many patients had
received an antibiotic prescription in this time.
Statistical analysis was conducted using Stata version 11.2
and Microsoft Excel.
Ethics information
All data were anonymised prior to receipt by the authors.
Ethics approval for the study was given by the Independent
Scientific and Advisory Committee (of CPRD), and the London
School of Hygiene and Tropical Medicine Ethics Committee.
Results
The study population comprised 1,534,443 patients from 625
practices across the UK (Table 1). Over half the participants
were aged 65-69 at the start of the study and 56% were
female. Median period of patient follow-up was 5.1 years
(interquartile range (IQR): 2.3-9.2). HES-linked information was
available for 59.7% of patients, whose characteristics were
largely similar to those of the whole cohort (Table 1).
Incidence by age and sex
Over the 14-year study period, 974,121 episodes of
community-acquired LRTI were identified in 448,469 patients
(median number of episodes=1, IQR:1-2). The median age at
diagnosis was 76 (IQR:70-82) years. Crude overall LRTI
incidence was 122.93 episodes/1000 person-years (IQR:
122.49-123.37/1000 person-years); incidence generally
increased over time with some fluctuations, from a low of
100.96 (1997) to a peak of 148.04/1000 person-years (2008),
and was similar in men and women (Figure 1a & Table S1).
After standardising for age the increase over time was less
marked, and a higher rate in men than women was revealed
(Figure 1a & Table S2).
The difference between the sexes was also apparent in the
age-stratified rates (Figure 2a,b), particularly in older age
groups. Incidence increased with age, doubling between the
65-69 and 85-89 age groups, and fluctuations over time were
more marked at older ages. Age-stratified results were not
presented graphically for those aged 90+, as the age structure
of this group varied over time, making the results difficult to
interpret (Table S1).
Inclusion of COPD exacerbation codes did not change the
overall pattern of LRTI incidence over time, but increased the
rates in both sexes by around 7% (Table S3 & Figure S1).
A total of 64,978 CAP episodes were identified in 58,772
patients. CAP patients were generally older than those with
LRTI (median age=81 years, IQR:75-87). Overall incidence of
CAP was 7.99/1000 person-years (IQR:7.92-8.07/1000 person-
years), was somewhat higher in men than women and
increased slightly over time (Figure 1b, Table S4). After
standardising for age, the increase was no longer apparent and
the higher rate in men than women was accentuated (Figure 1b
& Table S2). CAP rates increased with age with the rate in the
85-89 years group over seven times that of the 65-69 year olds
Table 1. Characteristics of the study population, for all
patients and for patients with HES-linked data.
 
Entire study
population  
HES-linked
patients
 n (%)  n (%)
Number of patients 1534443  916128 (59.7)
Median years follow-
up (IQR) 5.1 (IQR:2.3-9.2)  5.3 (IQR:2.3-9.6)
Sex    
Male 672858 (43.9)  402474 (43.9)
Female 861585 (56.1)  513654 (56.1)
Age at start of follow-
up    
65-69 819333 (53.4)  491205 (53.6)
70-74 237349 (15.5)  140743 (15.4)
75-79 197400 (12.9)  117298 (12.8)
80-84 142077 (9.3)  84533 (9.2)
85-89 89292 (5.8)  53559 (5.8)
90+ 48992 (3.2)  28790 (3.1)
Region practice is
baseda  
England only
%  
North East 29432 (1.9) 2.4 20615 (2.3)
North West 178011 (11.6) 14.5 145665 (15.9)
Yorkshire & The
Humber 71012 (4.6) 5.8 46482 (5.1)
East Midlands 60824 (4.0) 5.0 32744 (3.6)
West Midlands 130162 (8.5) 10.6 106627 (11.6)
East of England 150977 (9.8) 12.3 115749 (12.6)
South West 144749 (9.4) 11.8 128592 (14.0)
South Central 165094 (10.8) 13.5 110107 (12.0)
London 155219 (10.1) 12.7 106431 (11.6)
South East Coast 139681 (9.1) 11.4 103116 (11.3)
Northern Ireland 43633 (2.8)  N/A
Scotland 121428 (7.9)  N/A
Wales 144221 (9.4)  N/A
Index of Multiple
Deprivation (IMD)
quintiles relative to
country as a whole
   
Unavailable 712107 (46.4)  99150 (10.8)
0 (least deprived) 190874 (23.2)  189466 (23.2)
1 204589 (24.9)  203345 (24.9)
2 171462 (20.9)  170527 (20.9)
3 150185 (18.3)  149164 (18.3)
4 (most deprived) 105226 (12.8)  104476 (12.8)
a Hospital Episode Statistics (HES) data available for England only
doi: 10.1371/journal.pone.0075131.t001
Incidence of LRTI in UK Older Adults
PLOS ONE | www.plosone.org 3 September 2013 | Volume 8 | Issue 9 | e75131
(Figure 2c,d). Women’s CAP incidence was comparable to that
of men aged five years younger.
Incidence by region and deprivation
Incidence of both LRTI and CAP varied markedly by English
region (Figure 3). Age-standardised incidence of LRTI was
higher among the North and Midland regions than the South,
and was highest in the North West. For CAP, high rates were
seen in the North East, but also in the South Central region.
For both conditions, the lowest rates were in London and the
South East Coast. Rates are only presented for England; rates
for Scotland, Northern Ireland and Wales were not comparable,
due to lack of linked HES data outside England.
Incidence of both LRTI and CAP increased with increasing
deprivation, with a marked difference between IMD quintiles
three and four (the most deprived, Figure 4). This pattern was
Figure 1.  Incidence of LRTI and CAP by sex over time.  Crude and age-standardised incidence of a) LRTI and b) CAP by sex
over time. Standardised to UK population, mid-year 2004.
doi: 10.1371/journal.pone.0075131.g001
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present for both men and women, and remained after
standardising for age.
Antibiotic treatment of LRTI and CAP
More than three-quarters of LRTI patients were prescribed
antibiotics by their GP on the day their illness-episode was
diagnosed; 7.8% did not receive antibiotics but were
hospitalised (Table 2). Over half of CAP patients were
hospitalised on the day of diagnosis without a GP-prescribed
antibiotic on that day (58.2%), with death on the index date
without antibiotics or hospitalisation (13.0%) more common
than antibiotic receipt (9.9%). A larger percentage of CAP
(12.7%) than LRTI episodes (11.0%) had no antibiotic or
hospitalisation records in the 29 days after the index date
(Table 2). Of these CAP episodes, only 10% had received
antibiotics in the previous week. Penicillins, macrolides and
cephalosporins were the most commonly prescribed antibiotics
on the day for both conditions (Table 3).
Figure 2.  Incidence of LRTI and CAP by age and sex over time.  Incidence by age of LRTI in a) men, b) women and CAP in c)
men, d) women over time.
doi: 10.1371/journal.pone.0075131.g002
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Discussion
This is the first study to provide detailed estimates of the
burden of community-acquired LRTI and CAP among older UK
individuals over a prolonged time period. We have shown that
the incidence of LRTI and CAP increases markedly with age
within this older population. Those aged 85-89 years had
double the rate of LRTI and seven times more CAP illness-
episodes than those aged 65-69 years, and rates were
predominantly higher in men than women of the same age
group. Incidence varied between regions of England, with rates
in the North generally higher than the South. We also found
striking differences by IMD quintile, with incidence in the most
deprived quintile around 70% higher than the lowest quintile for
both LRTI and CAP. There was an increase in incidence of
both diseases over the study period, although rates did
fluctuate somewhat. The increase was attenuated after age-
standardisation, indicating that the rise was largely due to
Figure 3.  Age-standardised incidence of LRTI and CAP by region and sex.  Age-standardised incidence of a) LRTI and b) CAP
by region and sex. Standardised to UK population, mid-year 2004.
doi: 10.1371/journal.pone.0075131.g003
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Figure 4.  Age-standardised incidence of LRTI and CAP by IMD quintile and sex.  Age-standardised incidence of a) LRTI and
b) CAP by index of multiple deprivation quintile and sex.
Standardised to UK population, mid-year 2004.
doi: 10.1371/journal.pone.0075131.g004
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population aging. LRTIs were most commonly treated by an
antibiotic prescription from a GP, whereas over half of CAP
patients did not receive a GP antibiotic prescription but were
hospitalised on the illness index date.
Up to now there has been relatively little detailed information
on the incidence of these infections among the UK’s older
population. Importantly, our exclusion of person-time not at
risk, and identification of potentially hospital-acquired illness
provides more accurate estimates of community-acquired
infection than previously presented for UK older adults [1,7].
Table 2. Timing of antibiotic prescriptions and other
outcomes around the index date of LRTI and CAP illness-
episodes.
  LRTI  CAP  
Timing of
treatment
Treatment
received (all
mutually
exclusive)
 
Antibiotics
prescribed
in 7 days
before
index date
 
Antibiotics
prescribed
in 7 days
before
index date
  Total(%) n (%)
Total
(%) n (%)
On index
date
Antibiotics
prescribed
738794
(75.9) 22541 (3.1)
6412
(9.9) 777 (12.1)
 
Patient
hospitalised (no
GP antibiotics)
75453
(7.8) 8013 (10.6)
37830
(58.2) 4980 (13.2)
 
Patient died (no
GP antibiotics/
hospitalisation)
8094
(0.8) 937 (11.6)
8476
(13.0) 1450 (17.1)
1-7 days
after index
date
Antibiotics
prescribed
16116
(1.7) 1776 (11.0)
788
(1.2) 157 (19.9)
 
Patient
hospitalised (no
GP antibiotics)
5461
(0.6) 671 (12.3)
961
(1.5) 168 (17.5)
 
Patient died (no
GP antibiotics/
hospitalisation)
722
(<0.1) 123 (17.0)
399
(0.6) 102 (25.6)
8-28 days
after index
date
Antibiotics
prescribed
17406
(1.8) 2198 (12.6)
1155
(1.8) 208 (18.0)
 
Patient
hospitalised (no
GP antibiotics)
4497
(0.5) 27 (9.3)
610
(0.9) 72 (11.8)
 
Patient died (no
GP antibiotics/
hospitalisation)
291
(<0.1) 423 (9.1) 89 (0.1) 21 (23.6)
No treatment
recorded on
index date or
subsequent
28 days
 107287(11.0) 7355 (6.9)
8258
(12.7) 855 (10.4)
Total  974121(100.0) 44064 (4.5)
64978
(100.0) 8790 (13.5)
doi: 10.1371/journal.pone.0075131.t002
The derivation of illness-episodes allowed us to combine
repeat consultations for one illness, giving a better measure of
new illness compared to studies which included all
consultations or restricted analyses to the first consultation in a
year [7,8]. The incidence of LRTI we present is up to double
that reported in previous UK studies [1,8]. A key factor in the
age-adjusted increase in incidence in our study is likely to be
the improved survival of patients with co-morbidities, resulting
in a higher prevalence of patients at increased risk of infection
over time. Our CAP incidence rates are almost 20% higher
than previously reported in a similar UK GP population during a
slightly earlier period, although with similar trends by sex and
IMD [7].
Comparison of our findings with those from elsewhere in
Europe are restricted by the paucity of large European studies
of either LRTI or CAP set specifically in an older population, by
methodological differences and limitations of some studies, and
by real variation in the underlying risk profile of the populations
studied. Among LRTI studies, incidence of first LRTI among
85-90 year olds in a municipality in the Netherlands during the
first half of our study period estimated a considerably lower rate
(93.8/1000 person years) than that we present [20]. This small
study only included patients’ first episode of LRTI in incidence
estimates and did not exclude person-time spent in hospital,
which may explain much of the difference. Estimates from the
Second Dutch National Survey of General Practice
(2000-2002) were also lower than ours (70/1000 person-years
among those ≥75); again, person-time not at risk was not
excluded, and a different coding system for LRTI was used
[21].
Table 3. Variety of antibiotic (by BNF sub-chapter)
prescribed on the LRTI/CAP index date.
Antibiotic variety Number of varieties prescribed
(by BNFa sub-chapter)   
 LRTI CAP
 n (%) n (%)
Penicillins 511253 (69.2) 3662 (57.1)
Cephalosporins 64609 (8.8) 610 (9.5)
Tetracyclines 36785 (5.0) 218 (3.4)
Aminoglycosides 18 (<0.1) 1 (<0.1)
Macrolides 125343 (17.0) 1665 (26.0)
Clindamycin 22 (<0.1) 3 (<0.1)
Others 130 (<0.1) 4 (<0.1)
Sulphonamides 10577 (1.4) 80 (1.3)
Metronidazole 542 (<0.1) 16 (0.3)
Quinolones 28812 (3.9) 522 (8.1)
Nitrofurantoin & Methenamine 692 (0.1) 21 (0.3)
Two or more antibiotics 25 (<0.1) 0 (0.0)
Total varieties of Antibiotic 778808 (105.4*) 6802 (106.0*)
Patients prescribed to 738794 6412
a British National Formulary
* Total is more than 100% as some patients were prescribed more than one variety
of antibiotic
doi: 10.1371/journal.pone.0075131.t003
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Rates of CAP among older adults in Europe in the last 30
years have varied widely, both between and within countries.
Some of these were small regional studies, and/or were
restricted to either hospital or primary care settings. For
example, a Spanish cohort study (2002-2005) of individuals
aged ≥65 years set in the Tarragona region which did include
both outpatient and hospitalised cases estimated CAP
incidence at 14/1000 person years, twice that reported in this
paper; higher incidence was largely among 65-74 year olds [6].
An active surveillance program for CAP was established before
the start of the Spanish study, with primary care physicians
encouraged to register all CAP cases confirmed
radiographically. This could have changed primary care
physicians’ diagnostic practices for CAP. In addition, a high
proportion of individuals sought care directly from hospital and
not from their general practitioner. This may have resulted in a
somewhat more frequent categorisation of LRTI cases as CAP
compared to our study population, in which some younger less
severe cases would have been diagnosed and treated in
primary care (where radiological investigations for suspected
CAP are uncommon). In contrast, our CAP rates are
considerably higher than those presented by another small
Spanish study set in the Barcelona region in a slightly earlier
study period, which estimated CAP incidence as 3.16/1000
among those aged ≥65 [22]. Neither Spanish study removed
person-time not at risk of CAP nor age-standardised their
overall rates. A large Italian study gave a lower CAP incidence
estimate of 4.8/1000 population among those aged ≥65 years,
but was restricted to hospitalised cases [23]. Interestingly, a
large German study that also included only hospitalised CAP
patients reported CAP incidence in those aged ≥60 of
7.65/1000 population, similar to our findings [24]. As with our
study, the German and Italian studies reported consistently
higher rates in men and sharply rising incidence with increasing
age. Incidence of CAP was higher still in a small Finnish study
of both hospitalised and non-hospitalised CAP in 1981/2 at
19.9/1000 population [25]. The difference between this finding
and ours may be due in part to an earlier study period and
climatic differences. Comparisons of our CAP incidence
findings with those from the USA are less meaningful, as in the
US patients in long-term residential care with pneumonia are
not included with CAP but classified separately as having
healthcare-associated pneumonia, which is not recommended
practice in Europe [26].
During our study period routine vaccination for all older
adults against seasonal influenza and pneumococcal disease
was introduced, in 2000 and 2003 respectively. Yearly uptake
of influenza vaccine has increased from 65% in 2000 and has
remained between 71% and 75% since 2003 [27,28]. Coverage
of pneumococcal vaccination (PPV23) has increased steadily
from 29% of ≥65 year olds in 2003 to an estimated 70.5% by
31 March 2011 [29,30]. Thus our findings show rising LRTI and
CAP incidence despite increasing levels of influenza and
pneumococcal vaccine coverage. This might be in part
because effectiveness of the PPV23 vaccine among older
individuals appears to be limited [31].
As lower respiratory tract infections are caused by a number
of pathogens whose circulation and severity of resulting
disease varies from year to year, it is no surprise that LRTI
incidence fluctuates somewhat over time. However, the peak
LRTI incidence shown here in 2008 has not been reported
elsewhere. National reported laboratory data for England and
Wales do not show peaks in isolates of Mycoplasma
pneumoniae, respiratory syncitial virus or influenza A or B in
2008 [32,33]. It should be noted that this peak is emphasised
by the decrease in 2009, which could have resulted from low
susceptibility among older individuals to the pandemic strain of
influenza circulating in the 2009/10 season [34].
A high proportion of individuals with LRTI were given an
antibiotic prescription on the index date, similar to a previous
report from 1995–2000 [13]. It has been shown that among
patients aged ≥65 presenting with an LRTI, 4% of those not
prescribed antibiotics on the index date were diagnosed with
pneumonia in the next month, compared to 1.5% of those
prescribed antibiotics [35]. Higher antibiotic prescribing rates in
older people may be to prevent worsening of LRTI or
deterioration of co-morbidities, in line with recently issued
guidance [36].
The increase in LRTI and CAP with age is unsurprising given
age-related immunosenescence, and the growing prevalence
of co-morbidities within older groups. The previously
unreported regional differences between the North and South
of England shown in this study may be due to interrelated
socioeconomic and other factors, such as smoking and
nutritional habits, as well as extent of co-morbidities and lower
winter temperatures. It is notable that the regions with the
highest age-standardised LRTI rates (North West, Yorkshire
and the Humber, West Midlands and females in the North East)
also have high reported prevalence of smoking [37]. The high
level of CAP (but not LRTI) found in the South Central region
was unexpected, and we cannot currently explain this; it does
not appear to be due to a higher proportion of ‘oldest old’. We
cannot exclude the possibility that some of the regional
variation in CAP is due to different diagnostic preferences
geographically in categorising LRTI as CAP. However, we think
it unlikely that this would explain all of the marked variation
seen.
Hospitalisation without a GP antibiotic prescription was the
primary intervention for 58% of CAP episodes in this study.
Previous reports estimated that a third of all pneumonia
patients are treated in hospital [38]; we would expect this to be
higher among our older population. Penicillins and macrolides
were the most prescribed antibiotics, in line with British
Thoracic Society guidelines issued at the time [39]. CAP cases
who died on the index date (13%) will have included some
death notifications received by the GP. However, 12.7% of
CAP cases had no record of treatment or death on the index
date or the following four weeks, and only 10% of these
patients had received antibiotics in the preceding week.
Reasons for this may include high-risk patients taking
previously prescribed prophylactic antibiotics, or prescription of
antibiotics during a home visit that were incompletely captured
in the electronic record.
Our study has many strengths, being a large, population-
based study of over 1.4 million patients’ primary care records,
with additional information on hospital admissions for 59% of
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patients. The addition of linked HES admission/discharge dates
allowed better differentiation between potentially hospital- and
community-acquired illness-episodes. It also enabled exclusion
of person-time not at risk from the incidence calculation. Older
adults spend more time in hospital than their younger
counterparts, making this an important consideration. HES
linkage was not available for the whole study population, and
so we could not remove person-time at risk from the
denominator of all patients. This may have led to a slight
underestimation of incidence. However, we did use
hospitalisation codes recorded in CPRD to exclude potentially
hospital-acquired infections from the CPRD-only subset of the
data.
In primary care settings in the UK, GPs often diagnose
pneumonia without an x-ray, which may have led to some CAP
cases being categorised as LRTI and vice-versa.
Misclassification between other conditions (e.g. chronic
respiratory disease) and LRTI may have occurred in a minority
of patients over time, but is not likely to have favoured one
condition over the other. Clinical guidelines for the diagnosis of
LRTI did not change substantially during the study period but
we cannot exclude the possibility that increased awareness
and variation in clinical practice could have contributed in part
to some of the upward trend observed. Thus our estimates
reflect those of GP clinical opinion, in line with previous studies
[1,7,35,40].
We used an episode structure for illnesses due to the high
consultation rate among our study population [41]. The 28-day
period free from LRTI consultations specified as necessary
before a new episode could begin was chosen to be similar to
previous UK studies, which excluded patients if they had an
LRTI diagnosis up to 28 days before the index date [8,40]. It is
possible that using this period excluded a few new illnesses
from the numerator of our rate, and also excluded some
person-time at risk. The 14-day exclusion period we placed
after any hospitalisation is commonly used [14,16–19], but
again may have excluded some new community-acquired
episodes.
Conclusions
Community-acquired LRTI and CAP are important causes of
morbidity and mortality in the aging UK population. Our new
estimates show that the summary incidence of LRTI and CAP
commonly presented for the ≥65 age group considerably
underestimates UK disease rates in the higher ages within this
group. It is important that variations in LRTI and CAP incidence
in older individuals by age, region and IMD are taken into
account in future health planning in the UK. Routine data such
as these are used in many countries to assess disease burden.
Given our findings, our methodology is likely to be highly
relevant to other countries with aging populations, so that they
can obtain more accurate incidence estimates of these
important infections.
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